A rare case of Platypnoea-Orthodeoxia syndrome in COVID-19: BMJ report Dr Sravan Kumar2 Jun 2021 9:00 AM ISTClinical manifestations of COVID-19 which is caused by SARS-CoV2 range from mild upper respiratory symptoms to life-threatening severe acute...
Colchicine beneficial in COVID-19 RTCPR confirmed cases, Lancet study dr. Abhimanyu Uppal2 Jun 2021 9:00 AM ISTEvidence suggests a role for excessive inflammation in COVID-19 complications. Colchicine, an oral anti-inflammatory medication is hypothesized to...
Osimertinib improves survival in cases of lung cancer metastasis, finds study has Dr. Nandita Mohan1 Jun 2021 9:00 AM ISTResearch reveals that patients with T790M-positive, non-small-cell lung cancer (NSCLC) and multiple central nervous system (CNS) metastases after...
Corticosteroids in COVID-19: Answering all ifs, whens and buts for physicians. dr. Abhimanyu Uppal31 May 2021 12:45 PM ISTCOVID-19 infection has spread throughout the world as a rampant pandemic over the past one and half years. With no specific antiviral agent at hand,...
Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial Hina Zahid31 May 2021 8:00 AM ISTATS 2021, New York, NY - Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations...
Tracheostomy safe and effective in patients with COVID-19: JAMA Study Dr. Nandita Mohan29 May 2021 10:45 AM ISTAccording to a recent systematic review, it has been observed that tracheostomy is a relatively effective and safe treatment for patients with...
FDA Approves First Targeted Therapy for resistant Lung Cancer with specific genetic mutation Hina Zahid29 May 2021 10:00 AM ISTThe U.S. Food and Drug Administration has approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer...
Usual Care Without Antimicrobials sufficient for Patients with IPF: JAMA MD Bureau29 May 2021 9:00 AM ISTLung dysbiosis, observed as increased bacterial load and/or loss of diversity, has been reported in patients with idiopathic pulmonary fibrosis (IPF)....
Dupilumab helps reduce exacerbations in kids with moderate-to-severe asthma: VOYAGE trial Hina Zahid29 May 2021 9:00 AM ISTNew York, NY: Dupilumab (Dupixent) significantly reduced exacerbations in patients aged 6 to <12 years with uncontrolled, moderate-to-severe...
Colchicine effective option for non-hospitalized COVID-19 patients at risk of complications: Lancet Dr Kartikeya Kohli29 May 2021 8:45 AM ISTResearchers at Montreal Health Innovation Coordinating Centre (MHICC) have found in a phase 3, randomised, double-blinded, adaptive,...
Respiratory support with high flow nasal therapy lowers mortality in kids with pneumonia Dr. Nandita Mohan28 May 2021 9:00 AM ISTAccording to recent research conducted at the Department of Infectious Disease and Institute of Global Health and Innovation, Division of Medicine,...
Researchers report stroke in young adults after COVID-19 vaccination Medha Baranwal28 May 2021 9:00 AM ISTThe cases described suggest that, in addition to cerebral venous thrombosis, vaccine-induced immune thrombotic thrombocytopaenia (VTT) can also lead...
